Latest Market Strategy News

IPH Limited reported solid FY25 profit growth driven by Canadian acquisitions and a promising FY26 start despite challenges in Australia and New Zealand. CEO Andrew Blattman announced his retirement for late 2026, marking a pivotal leadership transition.

HeraMED has achieved a significant regulatory milestone with the Therapeutic Goods Administration upgrading its HeraBEAT fetal heart rate monitor to Class IIb, making it the only remote home-use device approved in Australia. This positions the company for a potentially lucrative expansion in the Australian maternity care market.

AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.

K2 Asset Management Holdings Ltd marked a pivotal year with 17% revenue growth and a return to profitability, declaring a fully franked dividend and outlining ambitious growth plans across its core business pillars.

Airtasker has raised $10 million in a strategic equity placement led by iHeartMedia, aiming to accelerate its growth in the US and UK markets through targeted marketing and expanded media partnerships.

Locksley Resources has partnered with Columbia University to develop cutting-edge, sustainable technologies for rare earth and critical mineral processing in the US, advancing its Mine-to-Market strategy amid growing government support.

Xero Limited reported a robust first half of FY26 with 20% revenue growth and strong cash generation, driven by sustained momentum across its core markets and the strategic Melio acquisition expanding its US footprint.

Vection Technologies has announced the acquisition of Monogic Limited, a digital marketing agency based in Hong Kong and Singapore, marking a significant step in its Asia Pacific expansion strategy. The deal enhances Vection’s AI and XR capabilities while adding immediate revenue and earnings contributions.

Atomos Limited has upgraded its FY26 earnings guidance, forecasting significant sales growth and a return to EBITDA profitability driven by strong demand and a revamped sales strategy.

Alliance Nickel’s binding offtake agreement with Stellantis is terminated due to missed milestones amid tough nickel market conditions, yet renegotiation talks signal ongoing partnership potential.

Proteomics International secures half a million dollars from the Western Australian Government to accelerate commercialisation of PromarkerEndo, a groundbreaking blood test for early endometriosis diagnosis.

CSL Limited’s latest Capital Markets Day presentation highlights CSL Seqirus’s strategic positioning to capitalize on a recovering US influenza vaccine market and global growth opportunities.